GL1X · GenesisL1 explorer

MolNFT v1 · #106219 · protein

X-ray structure of MERS-cov NSP5 protease bound with a designed inhibitor

4RSP · ORF1A protein: “X-ray structure of MERS-cov NSP5 protease bound with a designed inhibitor”. X-ray diffraction, 2 ligands (BOC, CEV), 2 pockets (best druggability 0.53). MolNFT v1 #106219 on GenesisL1: 3D structure, binding sites and…

PDB
4RSP
Type
protein
Length
307 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
ORF1A protein; Peptide inhibitor
UniProt
V9TU12
Ligands
BOC, CEV
Pockets
2 · best druggability 0.53

Structure

x-ray diffraction · 2 distinct chains · 24% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AORF1A proteinprotein30424% helix, 29% strandV9TU12
BPeptide inhibitorprotein30% helix, 33% strand—

Ligands and binding sites

  • BOC · Tert-butyl hydrogen carbonate · ligand · chains A, B
  • CEV · Ethyl (4R)-4-amino-5-[(3S)-2-oxopyrrolidin-3-yl]pentanoate · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12570.530.7640empty
2890.450.8020CEV

Interfaces

1 interface between chains.

  • A–B · 348 Ų buried · 7 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 3 covalent, 1 modified (covalent ligand, oxidation).

Compared structures

  • 4RSP · X-ray structure of MERS-CoV nsp5 protease bound with a designed inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.